Two-step in vivo tumor targeting by biotin- Conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T

Gabriella Baio, Marina Fabbi, Sandra Salvi, Daniela De Totero, Mauro Truini, Silvano Ferrini, Carlo Emanuele Neumaier

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Purpose: The purpose of this study was to assess two-step in vivo tumor targeting by specific biotin-conjugated antibodies and ultrasmall superparamagnetic iron oxide (USPIO)-anti-biotin nanoparticles as contrast agents for magnetic resonance imaging (MRI) at 1.5 T. Procedures: D430B human lymphoma cells, expressing the CD70 surface antigen, were injected either s.c. or i.v. to induce pseudo-metastases in NOD/SCID mice. Thirty micrograms of biotin-conjugated monoclonal anti-CD70 was injected i.v., followed 4 h later by 8 μmol Fe/Kg USPIO-anti-biotin. After 24 h, MRI was performed on T2* and b-FFE sequences. Signal intensity (SI) was calculated before and after USPIO-anti-biotin administration. Results: Subcutaneous xenografts showed a dishomogeneous 30% decrease in SI on T2* with anti-CD70+USPIO-anti-biotin treatment. Pseudo-metastatic xenografts showed a slight reduction in SI on T2*, but a 60% decrease in SI on b-FFE-weighted sequences. Prussian blue staining confirmed the presence of iron nanoparticles in the excised tumors. Conclusion: MRI at 1.5 T can detect tumors by a two-step in vivo biotin-based protocol, which may allow the targeting of any cell surface antigen.

Original languageEnglish
Pages (from-to)305-315
Number of pages11
JournalMolecular Imaging and Biology
Volume12
Issue number3
DOIs
Publication statusPublished - Jun 2010

Fingerprint

Biotin
Nanoparticles
Magnetic Resonance Imaging
Antibodies
Neoplasms
Surface Antigens
Heterografts
CD70 Antigens
Inbred NOD Mouse
SCID Mice
Contrast Media
Lymphoma
Iron
Staining and Labeling
Neoplasm Metastasis
ferumoxtran-10

Keywords

  • Antibody
  • In vivo small animal MRI
  • Iron oxide particles
  • Magnetic resonance imaging
  • Targeted contrast agent

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Two-step in vivo tumor targeting by biotin- Conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T. / Baio, Gabriella; Fabbi, Marina; Salvi, Sandra; De Totero, Daniela; Truini, Mauro; Ferrini, Silvano; Neumaier, Carlo Emanuele.

In: Molecular Imaging and Biology, Vol. 12, No. 3, 06.2010, p. 305-315.

Research output: Contribution to journalArticle

@article{02180fb6cf51432fb60d0985d596f36e,
title = "Two-step in vivo tumor targeting by biotin- Conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T",
abstract = "Purpose: The purpose of this study was to assess two-step in vivo tumor targeting by specific biotin-conjugated antibodies and ultrasmall superparamagnetic iron oxide (USPIO)-anti-biotin nanoparticles as contrast agents for magnetic resonance imaging (MRI) at 1.5 T. Procedures: D430B human lymphoma cells, expressing the CD70 surface antigen, were injected either s.c. or i.v. to induce pseudo-metastases in NOD/SCID mice. Thirty micrograms of biotin-conjugated monoclonal anti-CD70 was injected i.v., followed 4 h later by 8 μmol Fe/Kg USPIO-anti-biotin. After 24 h, MRI was performed on T2* and b-FFE sequences. Signal intensity (SI) was calculated before and after USPIO-anti-biotin administration. Results: Subcutaneous xenografts showed a dishomogeneous 30{\%} decrease in SI on T2* with anti-CD70+USPIO-anti-biotin treatment. Pseudo-metastatic xenografts showed a slight reduction in SI on T2*, but a 60{\%} decrease in SI on b-FFE-weighted sequences. Prussian blue staining confirmed the presence of iron nanoparticles in the excised tumors. Conclusion: MRI at 1.5 T can detect tumors by a two-step in vivo biotin-based protocol, which may allow the targeting of any cell surface antigen.",
keywords = "Antibody, In vivo small animal MRI, Iron oxide particles, Magnetic resonance imaging, Targeted contrast agent",
author = "Gabriella Baio and Marina Fabbi and Sandra Salvi and {De Totero}, Daniela and Mauro Truini and Silvano Ferrini and Neumaier, {Carlo Emanuele}",
year = "2010",
month = "6",
doi = "10.1007/s11307-009-0264-6",
language = "English",
volume = "12",
pages = "305--315",
journal = "Molecular Imaging and Biology",
issn = "1536-1632",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Two-step in vivo tumor targeting by biotin- Conjugated antibodies and superparamagnetic nanoparticles assessed by magnetic resonance imaging at 1.5 T

AU - Baio, Gabriella

AU - Fabbi, Marina

AU - Salvi, Sandra

AU - De Totero, Daniela

AU - Truini, Mauro

AU - Ferrini, Silvano

AU - Neumaier, Carlo Emanuele

PY - 2010/6

Y1 - 2010/6

N2 - Purpose: The purpose of this study was to assess two-step in vivo tumor targeting by specific biotin-conjugated antibodies and ultrasmall superparamagnetic iron oxide (USPIO)-anti-biotin nanoparticles as contrast agents for magnetic resonance imaging (MRI) at 1.5 T. Procedures: D430B human lymphoma cells, expressing the CD70 surface antigen, were injected either s.c. or i.v. to induce pseudo-metastases in NOD/SCID mice. Thirty micrograms of biotin-conjugated monoclonal anti-CD70 was injected i.v., followed 4 h later by 8 μmol Fe/Kg USPIO-anti-biotin. After 24 h, MRI was performed on T2* and b-FFE sequences. Signal intensity (SI) was calculated before and after USPIO-anti-biotin administration. Results: Subcutaneous xenografts showed a dishomogeneous 30% decrease in SI on T2* with anti-CD70+USPIO-anti-biotin treatment. Pseudo-metastatic xenografts showed a slight reduction in SI on T2*, but a 60% decrease in SI on b-FFE-weighted sequences. Prussian blue staining confirmed the presence of iron nanoparticles in the excised tumors. Conclusion: MRI at 1.5 T can detect tumors by a two-step in vivo biotin-based protocol, which may allow the targeting of any cell surface antigen.

AB - Purpose: The purpose of this study was to assess two-step in vivo tumor targeting by specific biotin-conjugated antibodies and ultrasmall superparamagnetic iron oxide (USPIO)-anti-biotin nanoparticles as contrast agents for magnetic resonance imaging (MRI) at 1.5 T. Procedures: D430B human lymphoma cells, expressing the CD70 surface antigen, were injected either s.c. or i.v. to induce pseudo-metastases in NOD/SCID mice. Thirty micrograms of biotin-conjugated monoclonal anti-CD70 was injected i.v., followed 4 h later by 8 μmol Fe/Kg USPIO-anti-biotin. After 24 h, MRI was performed on T2* and b-FFE sequences. Signal intensity (SI) was calculated before and after USPIO-anti-biotin administration. Results: Subcutaneous xenografts showed a dishomogeneous 30% decrease in SI on T2* with anti-CD70+USPIO-anti-biotin treatment. Pseudo-metastatic xenografts showed a slight reduction in SI on T2*, but a 60% decrease in SI on b-FFE-weighted sequences. Prussian blue staining confirmed the presence of iron nanoparticles in the excised tumors. Conclusion: MRI at 1.5 T can detect tumors by a two-step in vivo biotin-based protocol, which may allow the targeting of any cell surface antigen.

KW - Antibody

KW - In vivo small animal MRI

KW - Iron oxide particles

KW - Magnetic resonance imaging

KW - Targeted contrast agent

UR - http://www.scopus.com/inward/record.url?scp=77956707999&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956707999&partnerID=8YFLogxK

U2 - 10.1007/s11307-009-0264-6

DO - 10.1007/s11307-009-0264-6

M3 - Article

C2 - 19806404

AN - SCOPUS:77956707999

VL - 12

SP - 305

EP - 315

JO - Molecular Imaging and Biology

JF - Molecular Imaging and Biology

SN - 1536-1632

IS - 3

ER -